The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM) — STEM

Subdural Hematoma, Chronic Clinical Trial

Official title:
The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)

Status Active, not recruiting

Clinical Trial Summary

STEM Study is a pivotal, international, multi-center, prospective, randomized (1:1) controlled trial designed to provide an assessment of the safety and effectiveness of Middle Meningeal Artery (MMA) embolization with SQUID for the management of Chronic Subdural Hematoma (cSDH)

Clinical Trial Description

The study objective is to provide an assessment of the safety and effectiveness of Middle Meningeal Artery (MMA) embolization with SQUID for the management of Chronic Subdural Hematoma (cSDH). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04410146
Study type	Interventional
Source	Balt USA
Contact
Status	Active, not recruiting
Phase	N/A
Start date	November 1, 2020
Completion date	May 2024

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT06337851` - Comparing Simultaneous and Consecutive Drainage of Bilateral Chronic Subdural Hematoma	N/A
	Not yet recruiting	`NCT06274580` - Endovascular vs Conservative Treatment in Patients With Chronic Subdural Hematomas and Mild Symptoms	N/A